Among the top news today: UK grants emergency approval to Pfizer's coronavirus vaccine.
New data from Moderna's phase 3 trial confirm that the vaccine is highly effective and protects against severe disease.
Scientists around the world are creating dozens of unique vaccine candidates to fight the novel coronavirus — and they're doing it at unprecedented speeds.
He is known as the "father of fractals" for having discovered one of the most important patterns in nature.
Historians and scientists across Europe have now gotten together with perfumers and museums for a unique project.
The final efficacy analysis of its late-stage trial suggest Pfizer and BioNtech's vaccine is safe and effective at preventing COVID-19.
This comes a week after Pfizer announced similar results, providing hope that the world may soon have multiple vaccines that work effectively.
Both COVID-19 cases and hospitalizations are rising rapidly and exponentially, shattering records set in the spring.
This comes on the the tail of Pfizer's announcement that its experimental coronavirus vaccine may be more than 90% effective in preventing an infection.
The data is not yet published and the study is ongoing. But if this number holds up, it far exceeds public health experts' expectations.
Early hunter-gatherer women in the ancient Americas hunted big game just as much as men did, a new study suggests.
The earthquake caused the collapse of nearly 20 buildings in the city of Izmir. Search and rescue efforts are underway beneath the rubble.
Alaska's Tongass National Forest was protected from logging and other development for nearly two decades.
But even if vaccines are approved soon, several major roadblocks could significantly delay the timeline of distribution.
The study will test how much virus is needed to infect humans and which vaccines work the best to prevent COVID-19.